ArticleEuropean journal of ageing2025
MMSE in primary care practice: why good tests can mislead in the wrong context.
Article in European journal of ageing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prevalence and Severity of Cognitive Impairment Among Older Adults Using Benzodiazepines in Primary Care: Association with Duration of Use and Prescribing Pattern in Mexico.Healthcare (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Mini-Mental State Examination (MMSE) is widely used in cognitive screening, including in primary care settings. This study evaluated the diagnostic performance of the MMSE using data from 390 community-dwelling older adults aged 65 to 98 years (M = 75.76, SD = 6.76). The MMSE's accuracy was assessed against clinical diagnoses and symptom severity levels based on the Global Deterioration Scale (GDS). Receiver operating characteristic (ROC) analysis, evaluating the ability to distinguish individuals with dementia from those without, provided an area under the curve (AUC) of .75 (95% CI: 0.67-0.84, p < .001). The optimal cutoff based on Youden Index was 21 and resulted in a sensitivity of .77 (95% CI [.728, .812]) and specificity of .65 (95% CI [.603, .697]), whereas the more conventional cutoff (24) showed lower sensitivity (.50; 95% CI [.450, .550]) but higher specificity (.82; 95% CI [.782, .858]). At the suggested cutoff, the MMSE identified all cases at the severe stage, 88% at the moderate stage, and 31% at the mild stage of dementias, as classified by the GDS. In contrast, the Quick Mild Cognitive Impairment screen (Qmci) identified nearly all cases across severity levels. Against previous dementia diagnoses, when employing a cutoff score of 24 the MMSE had a positive predictive value of .52 (95% CI [.395, .645]) and a negative predictive value of .81 (95% CI [.726, .894]), indicating modest diagnostic reliability in a primary care context. Similar results were obtained applying a cutoff score of 21. These findings highlight how base rates and test characteristics shape test accuracy and should guide decision-making. Overall, our findings highlight that the MMSE can produce a substantial number of false positives in contexts with a relatively low prevalence of dementia, such as primary care, challenging the common assumption of its low false-positive rate. More broadly, our study emphasizes the importance of considering the prevalence of the condition in a given context, as differences in prevalence can drastically affect the interpretation of results, particularly the positive predictive value, even when sensitivity and specificity remain unaffected.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.